title: Chronic changes in skeletal muscle histology and function in peripheral arterial disease.
abstract: BACKGROUND
  Peripheral arterial disease (PAD) is associated with an impairment in exercise performance and muscle function that is not fully explained by the reduced leg blood flow during exercise. This study characterized the effects of PAD on muscle function, histology, and metabolism.
  
  
  RESULTS
  Twenty-six patients with PAD and six age-matched control subjects were studied. Ten of the PAD patients had unilateral disease, which permitted paired comparisons between their diseased and nonsymptomatic legs. All PAD patients had a lower peak treadmill walking time and peak oxygen consumption than controls. Vascular disease (diseased leg in unilateral patients and the most severely diseased leg in bilateral patients) was associated with decreased calf muscle strength compared with control values. In patients with unilateral disease, the diseased legs had a greater percentage of angular fibers (indicating chronic denervation) and a decreased type II fiber cross-sectional area (expressed as percent of total fiber area) compared with the nonsymptomatic, or control, legs. In diseased legs, gastrocnemius muscle strength was correlated with the total calf cross-sectional area (r = 0.78, p < 0.05) and type II fiber cross-sectional area (r = 0.63, p < 0.05). Activities of citrate synthase, phosphofructokinase, and lactate dehydrogenase in all 26 PAD patients (most diseased leg) did not differ from control values. Despite a wide range in citrate synthase activity in PAD patients, activity of this enzyme was not correlated with muscle strength or treadmill exercise performance.
  
  
  CONCLUSIONS
  In patients with PAD, gastrocnemius muscle weakness is associated with muscle fiber denervation and a decreased type II fiber cross-sectional area. In contrast, the PAD patients displayed substantial heterogeneity in muscle enzyme activities that was not associated with exercise performance. Denervation and type II fiber atrophy may contribute to the muscle dysfunction in patients with PAD and further confirm that the pathophysiology of chronic PAD extends beyond arterial obstruction.
authors.affiliation: Department of Medicine, University of Colorado School of Medicine, Denver.
authors.forename: J G
authors.initials: JG
authors.lastname: Regensteiner
authors.forename: E E
authors.initials: EE
authors.lastname: Wolfel
authors.forename: E P
authors.initials: EP
authors.lastname: Brass
authors.forename: M R
authors.initials: MR
authors.lastname: Carry
authors.forename: S P
authors.initials: SP
authors.lastname: Ringel
authors.forename: M E
authors.initials: ME
authors.lastname: Hargarten
authors.forename: E R
authors.initials: ER
authors.lastname: Stamm
authors.forename: W R
authors.initials: WR
authors.lastname: Hiatt
mesh_terms: D001158:Arteries; D005544:Forecasting; D006801:Humans; D008297:Male; D009132:Muscles / Q000201:enzymology / Q000473:pathology* / Q000503:physiopathology; D010807:Physical Endurance; D005082:Physical Exertion; D013997:Time Factors; D014652:Vascular Diseases / Q000201:enzymology / Q000473:pathology* / Q000503:physiopathology